Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Recruiting · NCT07149363 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-06-26 | NCT07149363 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alliance Foundation Trials, LLC. | 12 |
| AstraZeneca | 806 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| University of Illinois Chicago | Chicago | United States | 41 |
| University of Virginia Comprehensive Cancer Center | Charlottesville | United States | 7 |